We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$70.7B
AUM Growth
-$13.8B
Cap. Flow
-$8.71B
Cap. Flow %
-12.32%
Top 10 Hldgs %
10.57%
Holding
4,619
New
440
Increased
1,317
Reduced
2,164
Closed
637

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$777M
2
META icon
Meta Platforms (Facebook)
META
+$752M
3
TSLA icon
Tesla
TSLA
+$627M
4
CVX icon
Chevron
CVX
+$528M
5
SHOP icon
Shopify
SHOP
+$439M

Sector Composition

Rank Sector Weight
1 Healthcare 19.4%
2 Technology 18.51%
3 Consumer Staples 10.15%
4 Consumer Discretionary 9.67%
5 Financials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVM icon
3801
CEL-SCI Corp
CVM
$23.8M
$41K ﹤0.01%
439
-6,857
-94% -$826K
TNGX icon
3802
Tango Therapeutics
TNGX
$4.78B
$41K ﹤0.01%
+11,200
New +$47.8K
TCBP
3803
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
$41K ﹤0.01%
+1
New +$56.4K
KBNT
3804
DELISTED
Kubient, Inc. Common Stock
KBNT
$41K ﹤0.01%
42,196
-1,000
-2% -$1.09K
HMPT
3805
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$41K ﹤0.01%
26,800
+1,100
+4% +$3.37K
EQOS
3806
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$41K ﹤0.01%
102,759
+14,100
+16% +$9.26K
CEMI
3807
DELISTED
Chembio diagnostics, Inc.
CEMI
$41K ﹤0.01%
113,600
+90,100
+383% +$61.5K
RERE
3808
ATRenew
RERE
$917M
$40K ﹤0.01%
17,500
-10,800
-38% -$30K
XHG
3809
XChange TEC
XHG
$49.1M
$40K ﹤0.01%
1
RHE
3810
DELISTED
Regional Health Properties, Inc.
RHE
$40K ﹤0.01%
+16,345
New +$56.9K
BJDX icon
3811
Bluejay Diagnostics
BJDX
$1.03M
$39K ﹤0.01%
2
NAK
3812
Northern Dynasty Minerals
NAK
$896M
$39K ﹤0.01%
161,550
-202,947
-56% -$57.7K
RNTX
3813
Rein Therapeutics
RNTX
$65.3M
$39K ﹤0.01%
9,535
+3,775
+66% +$15.9K
THMO
3814
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$39K ﹤0.01%
3,467
+2,614
+306% +$26K
ALAR
3815
Alarum Technologies
ALAR
$14.3M
$38K ﹤0.01%
8,632
+30
+0.3% +$155
APLD icon
3816
Applied Digital
APLD
$9B
$38K ﹤0.01%
22,400
-5,700
-20% -$10.7K
CRMD icon
3817
CorMedix
CRMD
$590M
$38K ﹤0.01%
+13,600
New +$56.6K
EQ icon
3818
Equillium
EQ
$143M
$38K ﹤0.01%
17,200
+700
+4% +$1.67K
PPTA
3819
Perpetua Resources
PPTA
$2.59B
$38K ﹤0.01%
18,800
-6,300
-25% -$16.5K
RTB
3820
RTB Digital
RTB
$228M
$38K ﹤0.01%
111
+8
+8% +$2.88K
SCKT icon
3821
Socket Mobile
SCKT
$3.39M
$38K ﹤0.01%
17,700
+4,300
+32% +$12.1K
AVGR
3822
DELISTED
Avinger, Inc. Common Stock
AVGR
$38K ﹤0.01%
2,191
+260
+13% +$5.76K
MDNA
3823
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$38K ﹤0.01%
45,400
+13,300
+41% +$15K
BTOG icon
3824
Bit Origin
BTOG
$2.12M
$37K ﹤0.01%
52
+1
+2% +$711
IMMX icon
3825
Immix Biopharma
IMMX
$664M
$37K ﹤0.01%
+27,050
New +$59.1K

Similar funds

Renaissance Technologies's Q3 2022 Portfolio in Review

As of Q3 2022, Renaissance Technologies held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class A worth $498M.

  • Renaissance Technologies's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
  • Renaissance Technologies added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
  • Renaissance Technologies's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
  • Renaissance Technologies fully exited Shopify in Q3 2022, selling an estimated $439M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
  • Renaissance Technologies opened 440 new positions and closed 637 in Q3 2022.
  • Renaissance Technologies's portfolio value fell 16% quarter-over-quarter to $70.7B.

Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.